These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 20731647)

  • 1. Estimation of the distribution of infection times using longitudinal serological markers of HIV: implications for the estimation of HIV incidence.
    Sommen C; Commenges D; Vu SL; Meyer L; Alioum A
    Biometrics; 2011 Jun; 67(2):467-75. PubMed ID: 20731647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Principles and uses of HIV incidence estimation from recent infection testing--a review.
    Le Vu S; Pillonel J; Semaille C; Bernillon P; Le Strat Y; Meyer L; Desenclos JC
    Euro Surveill; 2008 Sep; 13(36):. PubMed ID: 18775292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunologic marker paths for seroconversion: single determinations of immunoglobulin A and beta 2-microglobulin are not adequate to estimate time of HIV infection. Multicohort Analysis Project Workshop. Part II.
    AIDS; 1994 Jul; 8(7):923-33. PubMed ID: 7946101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimation of incidence of HIV infection using cross-sectional marker surveys.
    Statten GA; Longini IM
    Biometrics; 1994 Sep; 50(3):675-88. PubMed ID: 7981394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for prevalent and incident HIV infection in a cohort of volunteer blood donors in Harare, Zimbabwe: implications for blood safety.
    McFarland W; Mvere D; Katzenstein D
    AIDS; 1997 Sep; 11 Suppl 1():S97-102. PubMed ID: 9376107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multistate approach for estimating the incidence of human immunodeficiency virus by using HIV and AIDS French surveillance data.
    Sommen C; Alioum A; Commenges D
    Stat Med; 2009 May; 28(11):1554-68. PubMed ID: 19278012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Testing bias in calculating HIV incidence from the Serologic Testing Algorithm for Recent HIV Seroconversion.
    Remis RS; Palmer RW
    AIDS; 2009 Feb; 23(4):493-503. PubMed ID: 19240458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New method for estimating HIV incidence and time from infection to diagnosis using HIV surveillance data: results for France.
    Ndawinz JD; Costagliola D; Supervie V
    AIDS; 2011 Sep; 25(15):1905-13. PubMed ID: 21811147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An age- and sex-structured HIV epidemiological model: features and applications.
    Low-Beer D; Stoneburner RL
    Bull World Health Organ; 1997; 75(3):213-21. PubMed ID: 9277008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance of an immunoassay at detecting recent infection among reported HIV diagnoses.
    Le Vu S; Meyer L; Cazein F; Pillonel J; Semaille C; Barin F; Desenclos JC
    AIDS; 2009 Aug; 23(13):1773-9. PubMed ID: 19593080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimated rate of HIV-1-infectious but seronegative blood donations in Bangkok, Thailand.
    Kitayaporn D; Kaewkungwal J; Bejrachandra S; Rungroung E; Chandanayingyong D; Mastro TD
    AIDS; 1996 Sep; 10(10):1157-62. PubMed ID: 8874634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assays for the detection of recent infections with human immunodeficiency virus type 1.
    Murphy G; Parry JV
    Euro Surveill; 2008 Sep; 13(36):. PubMed ID: 18775293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bootstrap confidence intervals and bias correction in the estimation of HIV incidence from surveillance data with testing for recent infection.
    Carnegie NB
    Stat Med; 2011 Apr; 30(8):854-65. PubMed ID: 21432879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Re: "Confidence intervals for biomarker-based human immunodeficiency virus incidence estimates and differences using prevalent data".
    Cole SR; Chu H
    Am J Epidemiol; 2007 Oct; 166(7):861-2. PubMed ID: 17709327
    [No Abstract]   [Full Text] [Related]  

  • 15. The epidemiology of HIV-1 infection in Victoria. The Victorian Collaborative Group on HIV and AIDS Surveillance (VCGHAS).
    Gertig D; Crofts N; Stevenson E; Breschkin A
    Med J Aust; 1993 Jan; 158(1):17-20. PubMed ID: 8417284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current incidence and estimated residual risk of transfusion-transmitted infections in donations made to Canadian Blood Services.
    O'Brien SF; Yi QL; Fan W; Scalia V; Kleinman SH; Vamvakas EC
    Transfusion; 2007 Feb; 47(2):316-25. PubMed ID: 17302779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prevalence of HIV infection in France before the introduction of early treatment: estimation by back-calculation].
    Rude N; Costagliola D; Valleron AJ
    Rev Epidemiol Sante Publique; 1993; 41(6):437-46. PubMed ID: 8296029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low avidity antibody: a reliable method to diagnose a recent HIV-1 infection.
    Re MC; Schiavone P; Vitone F; Bon I; De Crignis E; Biagetti C; Alessandrini F; Gibellini D
    New Microbiol; 2008 Jan; 31(1):19-26. PubMed ID: 18437838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mean Recency Period for Estimation of HIV-1 Incidence with the BED-Capture EIA and Bio-Rad Avidity in Persons Diagnosed in the United States with Subtype B.
    Hanson DL; Song R; Masciotra S; Hernandez A; Dobbs TL; Parekh BS; Owen SM; Green TA
    PLoS One; 2016; 11(4):e0152327. PubMed ID: 27065005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transmission of hepatitis B, hepatitis C and human immunodeficiency viruses through unsafe injections in the developing world: model-based regional estimates.
    Kane A; Lloyd J; Zaffran M; Simonsen L; Kane M
    Bull World Health Organ; 1999; 77(10):801-7. PubMed ID: 10593027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.